Teva Pharmaceuticals USA, Inc recalls Isotretinoin Capsules, USP, 40 mg, 10 count Prescription Pacs, Rx only, Manufactured for: Teva Pharmaceuticals USA, Inc…
- Recall date
- January 12, 2026
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0446-2026
- FDA classification
- Class II
- Brand / firm
- Teva Pharmaceuticals USA, Inc
- Sold / distributed
- FL, OH, PR & MS
Why it was recalled
Superpotent and Subpotent
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Isotretinoin Capsules, USP, 40 mg, 10 count Prescription Pacs, Rx only, Manufactured for: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054, NDC 0591-2436-15 (carton), NDC 0591-2436-45 (blister pack).
Get recall alerts
Free email alert whenever Teva Pharmaceuticals USA, Inc has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Teva Pharmaceuticals USA, Inc